TCR2 THERAPEUTICS INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Tcr2 Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q1 2023.
  • Tcr2 Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2023 was $5.81M, a 89.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $5.81M -$49.4M -89.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $22.5M -$5.77M -20.4% Dec 31, 2022 10-Q 2023-05-11
Q3 2022 $57.7M +$28.3M +96.1% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $62.3M +$31.7M +104% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $55.2M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $28.3M +$28.3M Dec 31, 2021 10-K 2023-03-23
Q3 2021 $29.4M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $30.6M Jun 30, 2021 10-Q 2021-08-05
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.